Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. [1] It is also used to treat chronic hepatitis B when other options are not possible. [1] It is effective against both HIV-1 and HIV-2. [1] It is typically used in combination with other antiretrovirals such as zidovudine, dolutegravir, and ...

Dolutegravir/lamivudine/tenofovir (DTG/3TC/TDF) is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. [1] It is a combination of dolutegravir, lamivudine, and tenofovir disoproxil. [1]

ndations for earlier neonatal treatment. The preferred treatment for infants 0-2 weeks old is zidovudine (AZT) + 3TC + nevirapine (NVP); for infants aged 2 weeks to 3 months old, the preferred treatment is abacavir (ABC) or AZT +. TC + lopinavir/ritonavir (LPV/r) syrup. As such, 3TC oral solution was added back to the limited use category o.

2024年6月27日 · Clinicians should choose a once-daily regimen using the once-daily dose of 3TC indicated above (approximately 3TC 10 mg/kg, with a maximum of 3TC 300 mg once daily). Child and Adolescent (Weighing ≥25 kg) and Adult Dose

2022年10月11日 · HBV/HIV co-infection: 150 mg twice daily or 300 mg once daily, combined with tenofovir and other appropriate antiretrovirals (HHS [adult] 2019). As Epivir: 3TC 300 mg PO once daily or 150 mg PO twice daily; As Combivir or Trizivir: 1 tab PO twice daily; As Epzicom: 1 tab PO once-daily; ADULT RENAL DOSING ADULT RENAL DOSING

Fixed-dose combination (FDC) of three antiretrovirals: HIV infection, according to strengths recommended by WHO. Post Exposure Prophylaxis (PEP) after accidental exposure to blood or body fluids. Two different codes depending on the packaging and the indication: DORATELD1T-: 90-tablets packaging preferred for HIV treatment.

2018年8月30日 · fixed-dose combination tablet of doravirine (100 mg), lamivudine (3TC, 300 mg) and tenofovir disoproxil fumarate (TDF, 300 mg); and PIFELTRO™ (doravirine, 100 mg), a new non-nucleoside reverse transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral medicines. Both DELSTRIGO and PIFELTRO are indicated for

Oral pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil fumarate (TDF) co-formulated with emtricitabine (FTC) or lamivudine (3TC) is recommended as an additional prevention option for persons at substantial risk of HIV infection by both the World Health Organization (WHO) and the US Pre …

In April 2019, the U.S. Food and Drug Administration approved a combination pill comprising the integrase inhibitor dolutegravir (DTG), 50 mg, and the NRTI lamivudine (3TC), 300 mg, for use as a complete ARV regimen for initial HIV treatment of patients.

2019年10月15日 · SYMFI is a three-drug fixed-dose combination product containing 600 mg of efavirenz (EFV), 300 mg of lamivudine (3TC), and 300 mg of tenofovir disoproxil fumarate (TDF). The recommended dosage of SYMFI in HIV-1-infected adults and pediatric patients who weigh at least 40 kg, and can swallow a solid tablet, is one tablet taken orally once daily.